The 2.3kg Assistive Wearable Redefines Personal Mobility with AI-Powered, Multi-Mode Support for Community Living LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — RoboCT,The 2.3kg Assistive Wearable Redefines Personal Mobility with AI-Powered, Multi-Mode Support for Community Living LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — RoboCT,

RoboCT Unveils Lightweight GoGo Exoskeleton Series at CES 2026, Pioneering Effortless Daily Mobility for All

2026/01/06 11:30
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

The 2.3kg Assistive Wearable Redefines Personal Mobility with AI-Powered, Multi-Mode Support for Community Living

LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — RoboCT, a leading innovator in exoskeleton robotics from China, makes its inaugural appearance at CES 2026 by unveiling its groundbreaking GoGo Exoskeleton series at the Pepcom media event. This launch signifies a pivotal strategic evolution for the company, extending its proven medical expertise into the realm of consumer-focused, daily life mobility solutions.

The centerpiece of the showcase, the GoGo series, embodies a user-centric design philosophy aimed at effortless mobility. Weighing a mere 2.3kg per side (excluding battery) and offering an operational range of up to 25km, it represents a significant leap towards practical, all-day wearability. Its intelligent system features multiple adaptive modes—including Walk, Stand/Sit, Cadence Assist, and Swing Assist—designed to support a diverse range of real-world activities. From aiding post-stroke gait recovery and providing stability for individuals with Parkinson’s to navigating community stairs and uneven terrain, GoGo adapts to the user’s needs in real-time.

“Our debut at CES is about demonstrating a new paradigm for assistive technology,” said Dr. WANG Tian, Founder and CEO of RoboCT. “With GoGo, we are moving exoskeletons out of specialized clinical settings and into the fabric of everyday life. Our goal is to provide a reliable, lightweight companion that empowers freedom of movement, whether for recovery, aging in place, or enhancing an active lifestyle.”

RoboCT’s confidence in bringing this technology to the consumer market is rooted in its solid medical heritage. The company’s established rehabilitation exoskeletons, like the UGO and KidGo series, have obtained key regulatory approvals including China’s NMPA Class II, FDA registration, and CE certification. GoGo inherits this legacy of safety, reliability, and clinical insight, repackaging it for accessibility.

About RoboCT:

Founded in 2017, RoboCT is a national high-tech enterprise with technological innovation as the core driving force. RoboCT is dedicated to the R&D and application of exoskeleton robotics, mainly in terms of core algorithms and components. Rehabilitation and elderly care are the current main focus, and RoboCT provides intelligent products and solutions for both medical institutions and individuals, based on a combined technology of human-computer interaction, artificial intelligence, data analysis, and cloud computing.

Media Contact:
Brenda GUAN Mengqi Public Relations Manager
guanmengqi@roboct.com
web:en.roboct.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/roboct-unveils-lightweight-gogo-exoskeleton-series-at-ces-2026-pioneering-effortless-daily-mobility-for-all-302652109.html

SOURCE RoboCT

시장 기회
Whalebit 로고
Whalebit 가격(CES)
$0.8135
$0.8135$0.8135
-1.69%
USD
Whalebit (CES) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!